COMMUNIQUÉS West-GlobeNewswire

-
Shire plc : Total voting rights
01/02/2018 - 14:01 -
Celtaxsys announces the issue of four new patents expanding its pipeline of selective leukotriene B4 modulation anti-inflammatory medicines
01/02/2018 - 14:00 -
Vericel to Present at the 7th Annual Leerink Partners Global Healthcare Conference
01/02/2018 - 14:00 -
Spero Announces Appointment of David P. Southwell to its Board of Directors
01/02/2018 - 14:00 -
Spectral Medical Announces the Appointment of Chief Financial Officer
01/02/2018 - 14:00 -
Delcath Announces Satisfaction of 2016 Convertible Note
01/02/2018 - 14:00 -
Evolve BioSystems Partners With King’s College London to Resolve Gut Dysbiosis in C-Section Delivered Infants
01/02/2018 - 14:00 -
First Patient Enrolled in AlloSure Registry
01/02/2018 - 14:00 -
Invuity to Present at Leerink Global Healthcare Conference
01/02/2018 - 14:00 -
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
01/02/2018 - 13:52 -
Making Breast Cancer Surgery Easier for Women: Over 25,000 Women in U.S. Experienced Wire-free Breast Tumor Localization with SAVI SCOUT®
01/02/2018 - 13:30 -
New Clinical Program at Amedisys for Heart Failure Patients Significantly Lowers Risks of Hospitalizations and Readmissions
01/02/2018 - 13:30 -
Progressive Care CEO, S. Parikh Mars Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
01/02/2018 - 13:30 -
Actinium Pharmaceuticals Announces Acceptance of Abstract for AACR Annual Meeting Highlighting Superior In Vivo Survival Data for Actinium Labelled Daratumumab Versus Unlabeled Daratumumab, A Blockbuster Product
01/02/2018 - 13:30 -
Emerald Health Therapeutics Achieves Tier 1 Listing on TSX Venture Exchange
01/02/2018 - 13:26 -
Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons
01/02/2018 - 13:01 -
Nabriva Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
01/02/2018 - 13:00 -
Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
01/02/2018 - 13:00 -
AxoGen, Inc. to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
01/02/2018 - 13:00
Pages